Oppenheimer reiterates Outperform rating on Tyra Biosciences; $40 target
Oppenheimer reiterated an Outperform rating on Tyra Biosciences and set a $40.00 price target, implying 55.9% upside versus the Sep 21 close of $25.65.
Oppenheimer reiterated an Outperform rating on Tyra Biosciences and set a $40.00 price target, implying 55.9% upside versus the Sep 21 close of $25.65.